Home
About
Portfolio
Meet the Team
News
Contact
Investor Portal
info@chv.vc
50 Braintree Hill Office Park Suite 301 Braintree, MA 02184
Home
/
News
/
Augmenix
Augmenix
Select a Company
Allegro Diagnostics (1)
Aria CV (4)
AtaCor Medical (4)
Augmenix (1)
Biocius (1)
BioTrove (1)
Conformal (9)
GI Dynamics (1)
Sera Prognostics (19)
nVision (1)
Maxwell Health (1)
Vortex Medical (1)
Novazyme Pharmaceuticals (1)
Saphena Medical (3)
PanTher Therapeutics (3)
Instylla Inc. (2)
Catalyst Health Ventures (2)
Epitel (2)
Avive (1)
Boston Scientific Closes $600m Augmenix Buyout
October 17, 2018
-
Augmenix
Let’s Connect.
Contact Us
